Skip to main content
SpringerLink
Log in

Mycoses in AIDS

  • Chapter
  • First Online:
Clinical Practice of Medical Mycology in Asia

  • 420 Accesses

Abstract

HIV infection associated CD4 depletion is an important defect leading to increased susceptibility to opportunistic as well as endemic fungal infections. Mucosal candidiasis, Pneumocystis jirovecii pneumonia (PJP), and cryptococcal meningoencephalitis were commonest invasive fungal infections identified during early HIV epidemic. Other endemic fungal infections like histoplasmosis and talaromycosis were also increasingly recognized in respective endemic areas after HIV epidemic. Patients with CD4 less than 200/cm3 are at a risk of getting life threatening fungal infections. Understanding of various mycosis in AIDS has improved over last three decades. PJP can be effectively prevented by cotrimoxazole prophylaxis. Advancement in fungal diagnosis and management improved the outcome of patients. Despite this progress in diagnosis and understanding of antifungal therapy, mortality with cryptococcal meningitis is very high especially in sub-Saharan African countries. Access to antiretroviral treatment has improved globally in reducing fungal infection rate. Early initiation of ART dramatically reduces the incidence of opportunistic infections in HIV including mycosis. HIV associated opportunistic and endemic mycosis is discussed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4:165rv13.

    Article  Google Scholar 

  2. Armstrong-James D, Meintjes G, Brown GD. A neglected epidemic: fungal infections in HIV/AIDS. Trends Microbiol. 2014;22:120–7.

    Article  CAS  Google Scholar 

  3. Antinori S, Nebuloni M, Magni C, et al. Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. Am J Clin Pathol. 2009;132:221–7.

    Article  Google Scholar 

  4. Park BJ, Shetty S, Ahlquist A, et al. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa. Int J STD AIDS. 2011;22:199–203.

    Article  CAS  Google Scholar 

  5. Nacher M, Adenis A, Sambourg E, et al. Histoplasmosis or tuberculosis in HIV-infected patients in the amazon: what should be treated first? PLoS Negl Trop Dis. 2014;8:e3290.

    Article  Google Scholar 

  6. Koss CA, Jarlsberg LG, den Boon S, et al. A clinical predictor score for 30-Day mortality among HIV-infected adults hospitalized with pneumonia in Uganda. PLoS One. 2015;10:e0126591.

    Article  Google Scholar 

  7. Le T, Wolbers M, Chi NH, et al. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City. Viet Nam Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011;52:945–52.

    Article  Google Scholar 

  8. Lim PL, Zhou J, Ditangco RA, et al. Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the treat Asia HIV observational database. J Int AIDS Soc. 2012;15(1):1.

    Article  CAS  Google Scholar 

  9. Hartung TK, Chimbayo D, van Oosterhout JJ, et al. Etiology of suspected pneumonia in adults admitted to a high-dependency unit in Blantyre. Malawi Am J Trop Med Hygiene. 2011;85:105–12.

    Article  Google Scholar 

  10. Ng VL, Yajko DM, Hadley WK. Extrapulmonary pneumocystosis. Clin Microbiol Rev. 1997;10:401–18.

    Article  CAS  Google Scholar 

  11. Alvarez-Martinez MJ, Miro JM, Valls ME, et al. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients. Diagn Microbiol Infect Dis. 2010;68:60–5.

    Article  CAS  Google Scholar 

  12. Crothers K, Beard CB, Turner J, et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS. 2005;19:801–5.

    Article  Google Scholar 

  13. Rabodonirina M, Vaillant L, Taffe P, et al. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia. Emerg Infect Dis. 2013;19:21–8. quiz 186

    Article  Google Scholar 

  14. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23:525–30.

    Article  Google Scholar 

  15. van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases mycoses study group and AIDS Clinical Trials Group. N Engl J Med. 1997;337:15–21.

    Article  Google Scholar 

  16. Day JN, Chau TT, Wolbers M, et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med. 2013;368:1291–302.

    Article  CAS  Google Scholar 

  17. Pappas PG, Chetchotisakd P, Larsen RA, et al. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2009;48:1775–83.

    Article  CAS  Google Scholar 

  18. Larsen RA, Bozzette SA, Jones BE, et al. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis. 1994;19:741–5.

    Article  CAS  Google Scholar 

  19. Bicanic T, Meintjes G, Wood R, et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis. 2007;45:76–80.

    Article  CAS  Google Scholar 

  20. Nussbaum JC, Jackson A, Namarika D, et al. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. Clin Infect Dis. 2010;50:338–44.

    Article  CAS  Google Scholar 

  21. Boulware D, Muzoora C, et al. ART initiation within the first 2 weeks of cryptococcal meningitis is associated with higher mortality: a multisite randomized trial. Program and abstracts of the 20th Conference on Retroviruses and Opportunistic Infections Atlanta, Georgia 2013.

    Google Scholar 

  22. Bisson GP, Molefi M, Bellamy S, et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clin Infect Dis. 2013;56:1165–73.

    Article  CAS  Google Scholar 

  23. da Cunha Colombo ER, Mora DJ, Silva-Vergara ML. Immune reconstitution inflammatory syndrome (IRIS) associated with Cryptococcus neoformans infection in AIDS patients. Mycoses. 2011;54:e178–82.

    Article  Google Scholar 

  24. Longley N, Harrison TS, Jarvis JN. Cryptococcal immune reconstitution inflammatory syndrome. Curr Opin Infect Dis. 2013;26:26–34.

    Article  CAS  Google Scholar 

  25. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet. 1994;344:110–3.

    Article  CAS  Google Scholar 

  26. Chariyalertsak S, Supparatpinyo K, Sirisanthana T. Nelson KE. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis. 2002;34:277–84.

    Article  CAS  Google Scholar 

  27. Supparatpinyo K, Nelson KE, Merz WG, et al. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother. 1993;37:2407–11.

    Article  CAS  Google Scholar 

  28. Woods JP. Revisiting old friends: developments in understanding Histoplasma capsulatum pathogenesis. J Microbiol. 2016;54:265–76.

    Article  CAS  Google Scholar 

  29. Nacher M, Adenis A, Aznar C, et al. How many have died from undiagnosed human immunodeficiency virus-associated histoplasmosis, a treatable disease? Time to act. Am J Trop Med Hyg. 2014;90:193–4.

    Article  Google Scholar 

  30. Theel ES, Harring JA, Dababneh AS, Rollins LO, Bestrom JE, Jespersen DJ. Reevaluation of commercial reagents for detection of Histoplasma capsulatum antigen in urine. J Clin Microbiol. 2015;53:1198–203.

    Article  CAS  Google Scholar 

  31. Adenis AA, Aznar C, Couppie P. Histoplasmosis in HIV-infected patients: a review of new developments and remaining gaps. Curr Trop Med Rep. 2014;1:119–28.

    PubMed  PubMed Central  Google Scholar 

  32. Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV medicine association/Infectious Diseases Society of America. MMWR Recomm Rep. 2004;53:1–112.

    PubMed  Google Scholar 

  33. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Accessed 28 June 2018.

    Google Scholar 

  34. Mylonakis E, Barlam TF, Flanigan T, Rich JD. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. Chest. 1998;114:251–62.

    Article  CAS  Google Scholar 

  35. Mylonakis E, Paliou M, Sax PE, Skolnik PR, Baron MJ, Rich JD. Central nervous system aspergillosis in patients with human immunodeficiency virus infection. Report of 6 cases and review. Medicine. 2000;79:269–80.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Diseases Clinic, “VEDANTA” Institute of Medical Sciences, Ahmedabad, India

    Atul K. Patel

Authors
  1. Atul K. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

    Arunaloke Chakrabarti

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Patel, A.K. (2020). Mycoses in AIDS. In: Chakrabarti, A. (eds) Clinical Practice of Medical Mycology in Asia. Springer, Singapore. https://doi.org/10.1007/978-981-13-9459-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-9459-1_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-9458-4

  • Online ISBN: 978-981-13-9459-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation